The Effect of Menopause and Menopausal Hormone Therapy on the Risk of Peripheral Artery Disease.
Menopause
menopausal hormone therapy
peripheral artery disease.
premature ovarian insufficiency
Journal
Current vascular pharmacology
ISSN: 1875-6212
Titre abrégé: Curr Vasc Pharmacol
Pays: United Arab Emirates
ID NLM: 101157208
Informations de publication
Date de publication:
2023
2023
Historique:
received:
13
06
2023
revised:
28
08
2023
accepted:
05
09
2023
medline:
23
11
2023
pubmed:
2
10
2023
entrez:
2
10
2023
Statut:
ppublish
Résumé
Peripheral artery disease (PAD), defined as lower extremity arterial disease, constitutes an underestimated aspect of the menopause-associated risk of atherosclerotic cardiovascular disease (ASCVD). Accumulation of ASCVD risk factors, such as atherogenic dyslipidaemia, diabetes, and arterial hypertension, after the transition to menopause may contribute to atherosclerotic plaque formation in peripheral arteries. However, inconsistency exists among studies as to whether transition to menopause increases the risk of PAD, although early menopause (<45 years) or premature ovarian insufficiency may accelerate peripheral atherosclerotic plaque formation. Menopausal hormone therapy may decrease the risk of PAD if administered early (
Identifiants
pubmed: 37779405
pii: CVP-EPUB-134686
doi: 10.2174/0115701611263345230919122907
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
293-296Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.